Patients aged over 45 admitted to hospital with exacerbations of chronic bronchitis alone or in association with cor pulmonale, pneumonia, or respiratory failure were placed in one of three groups (men with hypoxia, men without hypoxia, and women). Patients within these groups were then randomly allocated to receive either standard drug treatment alone or standard drug treatment plus intermittent positive-pressure ventilation (IPPV). No significant differences occurred between the controls and patients receiving physiotherapy and IPPV in any group.
Introduction
Acute exacerbations of chronic bronchitis are characterised by purulent sputum, airflow obstruction, and often hypoxaemia and hypercapnia.' In the United Kingdom physiotherapy is conventionally given to facilitate the removal of secretions. Physical adjuncts have been recommended,2 though the evidence remains scant.3 Slow deep breathing in emphysema,4 breathing exercises,5 voluntary hyperventilation, and intermittent positivepressure ventilation (IPPV) all have a beneficial effect on blood gas tensions, IPPV doing so at lower oxygen cost. 6 A Swedish study on bronchitic exacerbations showed no difference between patients given physiotherapy and controls in defervescence of fever or sputum volume;' and a laboratory study showed no clear benefit of physiotherapy in acutely ill people. 8 We have carried out a randomised controlled trial of physiotherapy and IPPV in patients admitted to this hospital irrespective of the severity of their bronchitic exacerbations.
Patients and methods
Patients of either sex were eligible for the trial if they had acute exacerbations of chronic bronchitis, were aged 45 or over, and were admitted between 1 November 1977 and 1 May 1978. An acute exacerbation of bronchitis was defined as an increase in cough, phlegm, or breathlessness for over 24 hours occurring in a patient with chronic bronchitis.9 Male patients were divided into two groups on the basis of their arterial oxygen tension (Pao,) on admission: group 1 comprised those whose Pao2 was over 8 0 kPa (60 mm Hg) and group 2 those with Pao2 <8 0 kPa. The women in the trial formed group 3. We then randomly allocated patients in each group to treatment with standard drug regimens plus physiotherapy and IPPV or standard drug regimens alone (controls), using prearranged sealed envelopes. Patients were excluded if they had renal, hepatic, or cardiac failure (other than cor pulmonale); malignant disease; tuberculosis; bronchial asthma or bronchiectasis; unstable angina; a myocardial infarction within the previous month; anaemia with a haemoglobin concentration under 11 g/dl; simple bronchitis with mucus hypersecretion but no airflow obstruction (ratio of forced expiratory volume in one second to vital capacity (FEV1:VC) less than 700, predicted, and in this study FEV1 less than 50°0 predicted); or a mental or physical state suggesting inability to co-operate in the trial.
The following factors were determined on admission: full blood count, erythrocyte sedimentation rate, urea electrolyte concentrations, liver function, Pao2, FEV1, and VC. Sputum culture and smear, electrocardiography, and chest x-ray examinations were also carried out. Viral antibodies were determined and blood culture performed when pneumonic consolidation was present. Pao2 was measured in all patients, breathing air, on admission and discharge. The 24-hour sputum volume was measured daily, and FEV1 :VC twice daily (at 09 00 and 15 00). Pao, in hypoxic patients was measured daily for the first week on oxygen. STANDARD 
TREATMENT
Patients received the following treatment: (1) antibiotics-oral tetracycline 500 mg four times daily, or ampicillin 500 mg four times daily if they were sensitive to tetracycline or had a blood urea concentration over 8 mmol/l (48 mg/100 ml). Any appropriate antibiotic was given for consolidation; (2) bronchodilators-salbutamol inhalation, two puffs six-hourly; (3) diuretics-frusemide up to 120 mg by mouth, then intravenously as necessary to achieve diuresis; and (4) oxygen-24°o by Ventimask at 4 1/min for all patients with hypoxia.
PHYSIOTHERAPY AND IPPV
Physiotherapy was given in a standard fashion'0 by means of conventional methods" to all patients allocated to receive it. It was given three times daily for 10-15 minutes depending on patient tolerance. IPPV was given at 09 00 by a physiotherapist and at 14 00 and 18 00 by a nurse, using 4 ml nebulised physiological saline over about 15 minutes.
CLINICAL RECORDS
These comprised (1) temperature, taken four times daily; (2) daily measurement of weight in patients with oedema; (3) daily eating score (nothing =0, being choosy = 1, eating most = 2, eating all = 3); (4) sleep score (no sleep = 0, under two hours= 1, most of night = 2, all night = 3); (5) results of an MRC bronchitis questionnaire recorded as soon as possible after admission (CB or HP); (6) results of Neuroticism Score Questionnaire (NSQ; Institute for Personality and Ability Testing, Illinois, USA), which was completed on admission and discharge; and (7) daily measurement of the distance walked in one minute along the corridor, unaided and self-paced.
Results
One hundred and two patients were admitted with acute exacerbations of chronic bronchitis without apparent complicating disease. Six had had physiotherapy before randomisation and so were excluded, and 12 were excluded after randomisation, due to misdiagnosis (five) or complicating diseases (seven). Of the remaining 84 patients, four died and one was ventilated (see table V). 
Discussion
An expert working party on intensive care in respiratory insufficiency unanimously concluded that physiotherapy was essential.'2 We examined our results to assess the importance of physiotherapy and to find useful criteria for recovery. The single difference between the groups was sputum volume. Patients in groups 1 and 2 who received physiotherapy and IPPV had a greater sputum volume, and although all showed a decrease in the last three days, the difference within group 1 was greater for those receiving physiotherapy and was significant at the 5 % level. We assumed that the decrease in sputum volume indicated clinical improvement, and interpreted the increased sputum volume of our male patients receiving physiotherapy and IPPV as being a desirable effect of that treatment. Increased sputum volume did not accelerate the improvement of patients receiving physiotherapy. The effect of physiotherapy on sputum volume remains small, and the relation between sputum volume and pulmonary function is not clear. The saline aerosol delivered by IPPV may have increased sputum volume.'3 From the satisfactory results seen in our control group, administering a bronchodilator by IPPV could produce at best only a small advantage, possibly in patients with the lowest pretreatment FEV1 (<075 1).14 Observations of sleep and eating patterns were quantified using simple scales. Improved eating often anticipated improvement in FEVy and VC by several days, and improvement in Pao, was also gradual. A standard one-minute walking test was included to ensure equal mobilisation, and in such disabled patients walking is an integral test of cardiorespiratory function. We noted a similar correlation between our one-minute walking test and VC as was seen in a more detailed 12-minute test. 15 The one-minute test allows a direct feedback of improvement to the patient. It was retrospectively evident that patients who died after leaving hospital had performed extremely poorly on this test ( <50 m/min).
We were concerned that patients not receiving physiotherapy might feel deprived of treatment. NSQ personality tests did not show any hidden psychological benefit of either physiotherapy or IPPV. All our patients received considerable attention, and twice-daily spirometry may have been therapeutic; this was necessary for monitoring progress and does not negate the results in the controls. The twice-daily objective and subjective observations by the physiotherapists were useful; their role in monitoring progress should be extended. When a patient with chronic bronchitis and respiratory failure is deteriorating, emphasis on correct diagnosis, fluid electrolyte balance, and nutrition together with judicious oxygen treatment are needed. The practice of intensifying physiotherapy in these patients is not supported by the evidence.
